ZACKS
搜索文档
Newmont Corporation (NEM) Outperforms Broader Market: What You Need to Know
ZACKS· 2026-01-05 23:51
In the latest close session, Newmont Corporation (NEM) was up +2.28% at $103.53. This change outpaced the S&P 500's 0.64% gain on the day. At the same time, the Dow added 1.23%, and the tech-heavy Nasdaq gained 0.69%. Coming into today, shares of the gold and copper miner had gained 12.77% in the past month. In that same time, the Basic Materials sector gained 5.72%, while the S&P 500 gained 0.55%. The investment community will be closely monitoring the performance of Newmont Corporation in its forthcoming ...
Venezuela Shock 2026: Defense, Tech, Healthcare Stocks Set to Benefit
ZACKS· 2026-01-05 21:01
文章核心观点 - 2026年初美国对委内瑞拉的军事行动构成重大地缘政治冲击 但全球石油市场的短期供应影响有限 因为该国当前产量仅占全球约1%且产能恢复缓慢[1][3][5] - 此次事件的结构性影响更可能体现在国防、科技和医疗保健等行业 这些行业将受益于安全支出增加和需求稳定性[7][10][13] - 地缘政治格局的演变正推动全球体系从单极向多极转变 这可能使地缘政治风险溢价持续存在 并使与政策相符的行业选择对投资者更为关键[14] 委内瑞拉对能源股的短期战略影响 - 委内瑞拉拥有全球最大的已探明石油储量 约3030亿桶 占全球储量的17-18% 但当前原油产量已崩溃至每日不足200万桶 远低于数十年前的约350万桶/日[3] - 任何有意义的产量提升都需要多年的资本支出、老旧设施的重大修复和政治稳定 难以在短期内带来供应激增[4] - 委内瑞拉目前仅占全球石油产量的约1% 雪佛龙作为唯一获准在委运营的美国主要石油公司 其在该国的业务对公司整体收入和现金流贡献份额很小 被视为长期战略期权而非近期盈利驱动因素[5][6] 受直接市场影响的三个行业 国防 - 国防股是地缘政治紧张时期最直接的受益者 历史事件如9/11后的安全建设、2014年克里米亚并入及持续的俄乌战争均伴随着美国主要国防承包商的持续优异表现[8] - 此次干预可能强化国防支出的较高基线 特别是在航空航天、监视、导弹系统和物流领域 洛克希德·马丁、诺斯罗普·格鲁曼和通用动力等大型国防承包商倾向于从长期合同、不断增长的订单积压和强劲的现金流可见性中受益[9] 科技 - 科技股通常通过风险情绪渠道而非直接收入敞口作出反应 在地缘政治冲击初期 高估值股票常面临压力 但中期内 科技生态系统的特定细分领域历来受益于安全驱动的支出增加[11] - 随着公共和私营部门对综合网络安全解决方案的需求持续增长 CrowdStrike Holdings和Palo Alto Networks等公司是这些趋势的主要受益者[11] 医疗保健 - 医疗保健股在地缘政治不确定性期间通常表现出相对的韧性 这源于需求的非弹性特性 制药、医疗器械和医疗保健服务公司基本不受冲突驱动的干扰[12] - 历史上 在避险时期医疗保健指数表现优于周期性板块 起到投资组合稳定器的作用 强生、雅培等大型多元化医疗保健公司 以及涉及诊断和医疗准备的国防相关医疗及生命科学供应商 会间接受益于全球不稳定时期政府对医疗准备、生物安全和供应链韧性的关注增加[12]
1 AI & 1 Quantum Stock Beat NVIDIA in 2025, Promise More Gains Ahead
ZACKS· 2026-01-05 21:01
Key Takeaways Two stocks beat NVIDIA in 2025, with D-Wave and Palantir delivering bigger gains than the AI chip leader. QBTS revenues nearly doubled year over year as Advantage2 rolled out, bookings rose, and its base expanded.PLTR revenues jumped on demand for its AI platform across government clients, lifting full-year 2025 sales.Despite U.S.-China trade headwinds, Wall Street’s most sought-after stock, NVIDIA Corporation (NVDA) , reported strong quarterly results throughout 2025, fueled by the artificial ...
McKesson Builds Earnings Momentum on Specialty and Automation
ZACKS· 2026-01-05 19:46
Key Takeaways McKesson posted strong Q2 results with $103B revenues up 10% YoY and adjusted EPS jumping 39%.McKesson's Oncology and Multispecialty segment drove results, with revenues up 32% and profit up 71%.McKesson raised full-year EPS guidance to $38.35-$38.85 as automation drove major cost leverage.McKesson Corporation (MCK) has delivered a strong fiscal second quarter, reinforcing confidence in management’s full-year outlook and longer-term strategic repositioning. The company reported consolidated re ...
Enbridge to Benefit From Rising Power Demand & Data Center Growth
ZACKS· 2026-01-05 19:46
Key Takeaways ENB transports roughly 20% of U.S. natural gas and is investing in natural gas infrastructure projects.ENB benefits as data center growth and the shift from coal to gas drive higher power demand and gas use.ENB is supported by expanding gas storage, a regulated utility business and investments in LNG infrastructure.Enbridge Inc. (ENB) is a leading midstream energy company in North America, transporting approximately 20% of the total natural gas consumed in the United States. The midstream play ...
KYMR Skyrockets 82.4% in a Year: More Upside Potential in 2026?
ZACKS· 2026-01-05 19:46
Key Takeaways KYMR surged after KT-621 showed deep STAT6 degradation and strong EASI and pruritus reductions.KT-621 cut multiple type 2 biomarkers and was mostly safe, supporting its potential as a once-daily therapy.FDA Fast Track and ongoing phase IIb AD and asthma studies position KT-621 for broader late-stage development.Kymera Therapeutics, Inc. (KYMR) has put up a stupendous performance over the past year. Shares of this clinical-stage biotechnology company have surged 82.4% over the said time frame c ...
MP Materials Trades at Premium Value: Here's How to Play the Stock
ZACKS· 2026-01-05 19:26
Key Takeaways MP stock surged 168.7% in a year, far outpacing the industry, sector and the broader market's returns.MP Materials secured Apple and DoW partnerships to strengthen a U.S. rare earth supply chain.MP Materials hit record NdPr output and expects return to profitability in 2026.MP Materials (MP) is trading at a forward 12-month price/sales multiple of 22.93X, a significant premium to the industry’s 1.44X. It has a Value Score of F, which suggests that the stock appears expensive and reflects a str ...
Energy Fuels Trades at Premium Value: Here's How to Play the Stock
ZACKS· 2026-01-05 19:21
Key Takeaways Energy Fuels mined more than 1.6M pounds of uranium in 2025, beating its prior target by 11%.UUUU expects 4Q25 uranium sales of 360,000 pounds and secured long-term contracts through 2032.Energy Fuels remains debt-free and has advanced rare earths, but trades at a big sales multiple.Energy Fuels (UUUU) is currently trading at a forward price-to-sales ratio of 37.18X, a significant premium to the non-ferrous mining industry’s 4.30X.UUUU’s Value Score of F suggests that the stock is not so cheap ...
Is Phillips 66's Midstream Push Building More Resilient Business?
ZACKS· 2026-01-05 19:16
Key Takeaways Phillips 66 benefits from weak oil prices as lower WTI levels support its downstream refining economics.PSX earns stable, fee-based cash flow from midstream assets contracted to shippers regardless of utilization.PSX is expanding midstream and chemicals to add cash flow and strengthen its business model.Phillips 66 (PSX) is an integrated downstream player that refines crude oil into final products. It also transports and stores crude oil, natural gas, NGL and refined products through its pipel ...
Wells Fargo Stock Jumps Nearly 19% in 3 Months: Right Time to Buy?
ZACKS· 2026-01-05 19:10
股价表现与市场定位 - 富国银行股价在过去三个月上涨18.6%,表现优于行业9.1%的涨幅,其同行花旗集团和美国银行同期分别上涨21.8%和11.6% [1] - 尽管近期表现强劲,但分析认为富国银行的上涨行情远未结束,其基本面改善和战略调整增强了投资者信心 [5][23] 监管限制解除与增长潜力 - 美联储于2025年6月解除了自2018年虚假账户丑闻后对富国银行实施的资产上限限制,消除了其资产负债表扩张的长期约束 [6] - 监管松绑使公司能够增加存款、扩大贷款余额和证券持有量,并为其费用业务(如支付服务、资产管理和抵押贷款发起)的扩展提供了更大灵活性 [6][7] - 管理层将中期有形普通股回报率目标从15%上调至17-18%,预示着未来几年更强的盈利能力前景 [8] 净利息收入前景 - 富国银行的净利息收入在截至2024年的三年间实现了10%的复合年增长率,但在2025年前九个月同比下降1.9%至351.5亿美元,主要受融资成本上升压力影响 [11] - 随着2024年初始降息及2025年后续三次降息,利率目前处于3.50-3.75%区间,预计融资成本将逐步稳定,借款增加将推动贷款量增长,从而支持净利息收入在未来几个季度实现可观增长 [12] - 公司预计2025年净利息收入将与2024年的477亿美元持平 [12] 业务简化与战略重组 - 自2019年以来,在首席执行官领导下,公司持续推进战略简化计划,旨在退出非核心及低回报业务,聚焦于消费银行、商业贷款和高回报领域,目标每年削减高达100亿美元成本 [13] - 近期资产剥离包括:2025年5月同意将铁路租赁组合出售给GATX和布鲁克菲尔的合资企业;2025年3月完成向Trimont出售非机构第三方商业抵押贷款服务业务;2023年出售了约20亿美元的私募股权基金投资 [14][15] - 更早的剥离包括2021年出售资产管理、企业信托服务和加拿大直接设备融资业务,2019年出售机构退休与信托业务,以及2018年剥离波多黎各汽车金融部门 [16] - 这些举措旨在降低运营成本、提高资本效率,并将资源重新配置到高回报领域 [17] 成本控制与运营优化 - 公司积极采取成本削减措施,包括精简组织结构和减少员工数量,预计到2025年底将实现150亿美元的总费用节约 [10][22] - 截至2025年第三季度末,分支机构数量同比下降2.1%至4,108家,公司同时投资于分支机构翻新和新址建设,作为更广泛增长战略的一部分,预计到2025年底将完成超半数分支网络的更新 [18][19] - 2025年第三季度员工人数同比减少4.3%,并暗示2026年员工规模可能进一步缩减,作为提高效率和推广人工智能应用的一部分 [21] - 公司通过与谷歌云扩大战略合作伙伴关系,分阶段推出人工智能工具,旨在提高生产力、简化工作流程并提升客户服务 [20] 财务预测与估值 - Zacks共识预期显示,公司2025年和2026年销售额预计分别增长2.1%和5.4%,每股收益预计分别增长16.9%和11.7% [24] - 具体季度预测:当前季度销售额预计215.8亿美元,同比增长5.91%;下一季度预计217.2亿美元,同比增长7.82% [25] - 当前季度每股收益预计1.65美元,同比增长16.20%;下一季度预计1.51美元,同比增长18.90% [28] - 公司估值具有吸引力,其12个月追踪市盈率为13.55倍,低于行业平均的15.24倍,也低于美国银行的12.89倍和花旗集团的11.79倍 [30] 资本回报与股东价值 - 公司在过去五年中六次提高股息,年化增长率为29.3%,并设有股票回购计划 [29] - 截至2025年9月30日,公司剩余授权可回购高达347亿美元的普通股,其强劲的资本状况和充足的流动性使得资本回报活动具有可持续性 [29][30]